Skip to main content

Table 4 Regression analysis for CI-AKI predictors after second agent

From: Predictors of contrast-induced acute kidney injury in patients with coronary artery disease receiving contrast agents twice within 30 days

VariableUnivariate analysisMultivariate analysis
P valueOR95% CIP value
Interval time0.0331.1701.980–2.3700.037
Female0.2321.4600.660–3.2260.350
NYHA class II-III0.0561.3810.576–3.3090.469
Hypertension0.0642.1070.929–4.7740.074
Diabetes0.1351.2960.582–2.8880.526
Diuretics0.0121.2680.489–3.2880.625
CCB0.7431.3290.601–2.9390.482
β-RB0.9180.6980.277–1.7590.446
ACEI/ARB0.1660.4280.191–0.9580.039
Statins0.1064.2030.809–21.8460.088
Digitalis0.0061.2910.453–3.6770.632
IABP0.0013.3021.055–10.3350.040
LM lesion0.1640.8800.356–2.1770.782
Age0.4380.9960.963–1.0310.838
Basic SYNTAX score0.0831.0060.952–1.0630.838
CI-AKI post-first agent< 0.0013.4541.278–9.3330.015
  1. NYHA New York Heart Association, CCB Calcium channel blocker, β-RB β-receptor blocker, ACEI Angiotensin-converting enzyme inhibitor, ARB Angiotensin II receptor antagonist, IABP Intra-aortic balloon pump, LM Left main, SYNTAX Synergy between percutaneous coronary intervention with Taxus and cardiac surgery, CI-AKI Contrast-induced acute kidney injury